Abstract
Leukotoxin is a linoleic acic oxide produced by leukocytes and has been associated with the multiple organ failure and adult respiratory distress syndrome seen in some severe burn patients. Leukotoxin has been reported to be toxic when injected into animals intravenously. Herein, we report that this lipid is not directly cytotoxic in at least two in vitro systems. Using a baculovirus expression system we demonstrate that leukotoxin is only cytotoxic in the presence of epoxide hydrolases. In addition, it is the diol metabolite that proves toxic to pulmonary alveolar epithelial cells, suggesting a critical role for the diol in leukotoxin-associated respiratory disease. In vivo data also support the toxicity of leukotoxin diol. For the first time we demonstrate that soluble epoxide hydrolase can bioactivate epoxides to diols that are apparently cytotoxic. Thus leukotoxin should be regarded as a protoxin corresponding to the more toxic diol. This clearly has implications for designing new clinical interventions.
Similar content being viewed by others
Article PDF
References
Hayakawa, M. et al. Neutrophils biosynthesize leukotoxin, 9,10-epoxy-12-octadecenoate. Biochem. Biophys. Res. Commun. 137, 424–430 (1986).
Fukushima, A. et al. Cardiovascular effects of leukotoxin (9,10-epoxy-12-octadecenoate) and free fatty acids in dogs. Cardiovasc. Res. 22, 213–218 (1988).
Ozawa, T. et al. Leukotoxin, 9,10-epoxy-12-octadecenoate, as a burn toxin causing adult respiratory distress syndrome. Adv. Prostaglandin Thromboxane Leukot. Res. 21B, 569–572 (1991).
Kosaka, K. et al. Leukotoxin, a linoleate epoxide: Its implication in the late death of patients with extensive burns. Mol. Cell. Biochem. 139, 141–148 (1994).
Pacht, E.R. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100, 1397–1403 (1991).
Sevanian, A., Mead, J.F. & Stein, R.A. Epoxides as products of lipid autooxidation in rat lungs. Lipids 14, 634–643 (1979).
Hammock, B.D., Grant, D.F. & Storms, D. Epoxide hydrolases. in Comprehensive Toxicology (eds. Sipes, I.G., McQueen, C.A. & Gandolfi, A.J.) Ch. 18 (Pergamon, Oxford) (in the press).
Moghaddam, M.F., Motoba, K., Borhan, B., Pinot, F. & Hammock, B.D. Novel metabolic pathways for linoleic acid and arachidonic acid metabolism. Biochem. Biophys. Acta 1290, 327–339 (1996).
Vogel-Bindel, U., Bentley, P. & Oesch, F. Endogenous role of microsomal epoxide hydrolase: Ontogenesis, induction, inhibition, tissue distribution, immunologicalbehaviour and purificationof microsomal epoxidehydrolase with 16α,17α-epoxyandrostene-3-one as substrate. Eur. J. Biochem. 126, 425–431 (1982).
Kaur, S. & Gill, S.S. Age-related changes in the activities of epoxide hydrolases in different tissues of mice. Drug Metab. Dispos. 13, 711–715 (1985).
Gill, S.S. & Hammock, B.D. Hydration of cis-and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver. Biochem. Biophys. Res. Commun. 89, 965–971 (1979).
Borhan, B., Nourooz-Zadeh, J., Uematsu, T., Hammock, B.D. & Kurth, M.J. Improved radiolabeled substrates for soluble epoxide hydrolase. Anal. Biochem. 231, 188–200 (1995).
Grant, D.F., Storms, D.H. & Hammock, B.D. Molecular cloning and expression of murine liver soluble epoxide hydrolase. J. Biol. Chem. 268, 17628–17633 (1993).
Beetham, J.K., Tian, T. & Hammock, B.D. cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch. Biochem. Biophys, 305, 197–201 (1993).
Grant, D.F. et at. Development of an in situ toxicity assay system using recombinant baculoviruses. Biochem. Pharmacol. 51, 503–515 (1996).
Jerina, D.M. et al. Bay-Region epoxides of dihydrodiols: A concept explaining the mutagenic and carcinogenic activity of benzo[a]pyrene and benzo[a]anthracene. in Origins of Human Cancer (eds. Hiat, H.H., Watson, J.D. & Winsten, J.A.) 639–658 (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977).
Cheek, J.M., Kim, K-J. & Crandall, E.D. Tight monolayers of rat alveolar epithelial cells: Bioelectric properties and active sodium transport. Am. J. Physiol. 256, C688–C693 (1989).
Taylor, A.E. & Gaar, K.A. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am. J. Physiol. 218, 1133–1140 (1970).
Casals, C. et al. Association of changes in lysophosphatidylcholine metabolism and in microsomal membrane lipid composition to the pulmonary injury induced by oleic acid. Biochem. Biophys. Acta 1023, 290–297 (1990).
Cheek, J.M. et al. Ozone injury to alveolar epithelium in vitro does not reflect loss of antioxidant defenses. Toxicol. Appl. Pharmacol. 125, 59–69 (1994).
Jia-ning, H. et al. Neutrophil-derived epoxide, 9,10-epoxy-12-octadecenoate, induces pulmonary edema. Lung 166, 327–337 (1988).
Hayakawa, M. et al. Proposal of leukotoxin, 9,10-epoxy-12-octadecenoate, as a burn toxin. Biochem. Int. 21, 573–579 (1990).
Ishizaki, T. et al. Leukotoxin, 9,10-epoxy-12-octadecenoate causes edematous lung injury via activation of vascular nitric oxide synthase. Am. J. Physiol. 269, L65–L70 (1995).
Ishizaki, T. et al. Increased nitric oxide biosynthesis in leukotoxin, 9,10-epoxy-12-octadecenoate injured lung. Biochem. Biophys. Res. Commun. 210, 133–137 (1995).
Sakai, T. et al. Leukotoxin, 9,10-epoxy-l2-octadecenoate inhibits mitochondrial respiration of isolated perfused rat lung. Am. J. Physiol. 269, L326–L331 (1995).
Ishizaki, T. et al. Increased nitric oxide biosynthesis in leukotoxin, 9,10-epoxy-12-octadecenoate injured lung. Am. J. Physiol. 268, L123–L128 (1995).
Mullin, C. et al. Chalcone oxides — potent selective inhibitors of cytosolic epoxide hydrolase. Arch. Biochem. Biophys. 216, 423–439 (1980).
Hammock, B. et al. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities. Toxicol. App. Pharmacol. 71, 254–265 (1983).
Gibson, G. et al. Induction of cytochrome P450 IVA 1-mediated fatty acid hydroxylation: Relevance to peroxisome proliferation. Biochem. Soc. Trans. 18, 97–99 (1990).
Nelson, S. & Pearson, D. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30, 169–195 (1990).
Borhan, B., Nourooz-Zadeh, J., Uematsu, T., Hammock, B.D. & Kurth, M.J. Stereochemical aspects of cytosolic epoxide hydrolase hydration of methyl diepoxystearates. J. Tetrahedron 49, 2601–2612 (1993).
Ozawa, T. et al. Biosynthesis of leukotoxin, 9,10-epoxy-12 octadecenoate, by leukocytes in lung lavages of rat after exposure to hyperoxia. Biochem. Biophys. Res. Commun. 134, 1071–1078 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moghaddam, M., Grant, D., Cheek, J. et al. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med 3, 562–566 (1997). https://doi.org/10.1038/nm0597-562
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0597-562
This article is cited by
-
Batokines: Mediators of Inter-Tissue Communication (a Mini-Review)
Current Obesity Reports (2022)
-
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
Alzheimer's Research & Therapy (2021)
-
Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors
Molecular Diversity (2021)
-
Hydroxy-octadecenoic acids instead of phorbol esters are responsible for the Jatropha curcas kernel cake’s toxicity
Communications Biology (2020)
-
Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain
Neurotherapeutics (2020)